Gyre Therapeutics Inc
(GYRE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,613 | -9,966 | -6,998 | -8,529 | 10,899 |
| Depreciation Amortization | 680 | 974 | 3,149 | 3,391 | 2,413 |
| Accounts receivable | 1 | -52 | -1,162 | 620 | 200,963 |
| Accounts payable and accrued liabilities | -106 | 11 | N/A | N/A | N/A |
| Other Working Capital | -477 | 2,420 | -10,220 | 10,346 | 207,319 |
| Other Operating Activity | 126 | 339 | -49,008 | -89,546 | -283,296 |
| Operating Cash Flow | $-6,389 | $-6,274 | $-64,239 | $-83,718 | $138,298 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 38,566 | -56,241 | -59,531 |
| PPE Investments | 98 | -41 | 1,256 | -1,426 | -3,268 |
| Investing Cash Flow | $98 | $-41 | $39,822 | $-57,667 | $-62,799 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,132 | 1,228 |
| Debt Repayment | N/A | N/A | -1,240 | -1,964 | -1,577 |
| Common Stock Issued | 25 | N/A | 614 | 82,646 | 3,292 |
| Other Financing Activity | 4,982 | 5,742 | 0 | 0 | 3,503 |
| Financing Cash Flow | $5,007 | $5,742 | $-626 | $82,814 | $6,446 |
| Beginning Cash Position | 2,828 | 3,401 | 107,283 | 165,854 | 83,909 |
| End Cash Position | 1,544 | 2,828 | 82,240 | 107,283 | 165,854 |
| Net Cash Flow | $-1,284 | $-573 | $-25,043 | $-58,571 | $81,945 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,389 | -6,274 | -64,239 | -83,718 | 138,298 |
| Capital Expenditure | N/A | -41 | -333 | -1,431 | -3,311 |
| Free Cash Flow | -6,389 | -6,315 | -64,572 | -85,149 | 134,987 |